TY - JOUR T1 - Functional activation changes at ultra-high field related to upper and lower limb impairments in multiple sclerosis JF - medRxiv DO - 10.1101/2020.08.13.20174664 SP - 2020.08.13.20174664 AU - Myrte Strik AU - Camille J. Shanahan AU - Anneke van der Walt AU - Frederique M. C. Boonstra AU - Rebecca Glarin AU - Mary P. Galea AU - Trevor J. Kilpatrick AU - Jeroen J.G. Geurts AU - Jon O. Cleary AU - Menno M. Schoonheim AU - Scott C. Kolbe Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/15/2020.08.13.20174664.abstract N2 - Upper and lower limb impairments are common in people with multiple sclerosis (pwMS), yet difficult to clinically identify in early stages of disease progression. Tasks involving complex motor control can potentially reveal more subtle deficits in early stages, and can be performed during functional MRI acquisition, to investigate underlying neural mechanisms, providing markers for early motor progression. We investigated brain activation during visually-guided force-matching of hand or foot in 28 minimally disabled pwMS and 17 healthy controls (HC) using ultra-high field 7-Tesla fMRI, allowing us to visualise sensorimotor network activity in high detail. Task activations and performance (tracking lag and error) were compared between groups, and correlations were performed. PwMS showed delayed (+124 s, p=0.002) and more erroneous (+0.15 N, p=0.001) lower limb tracking, together with higher primary motor and premotor cortex activation, and lower cerebellar activation compared to HC. No differences were seen in upper limb performance or activation. Functional activation levels of cerebellar, visual and motor areas correlated with task performance. These results demonstrate that ultra-high field fMRI during complex hand and foot tracking can identify subtle impairments in movement and brain activity, and differentiates upper and lower limb impairments in minimally disabled pwMS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the University of Melbourne (Melbourne Neuroscience Institute Interdisciplinary Seed Grant to SK and Melbourne International Research Scholarship to MS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval was obtained from the Melbourne Health Human Research Ethics Committee and all participants provided a voluntary written consent prior to participation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymised data is available from the corresponding author upon request. ER -